TEST STRIP MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

The Global Test Strip Market is estimated to be valued at USD 14.25 Bn in 2025 and is expected to reach USD 18.38 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 3.7% from 2025 to 2032. The market growth is driven by factors such as the increasing prevalence of chronic diseases, the growing geriatric population, and the rising demand for point-of-care diagnostics.

Key Takeaways of the Global Test Strip Market

• By product type, glucose test strips are expected to dominate the market in 2025, accounting for the highest share at 29.2%, driven by the rising prevalence of diabetes globally and the critical need for regular blood glucose monitoring.
• By application, diabetes management is projected to lead the market with the largest share of 32.1% in 2025, driven by the growing emphasis on effective blood glucose monitoring and control to prevent diabetes-related complications.
• By end user, hospitals & clinics are projected to hold the largest market share at 32.2% in 2025, attributed to the high influx of patients requiring point-of-care testing and the availability of advanced diagnostic infrastructure in these settings.
• North America is expected to lead the market, holding a share of 44.3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 29.1% in 2025.

Market Overview

The market trend for the test strip market is characterized by the adoption of advanced technologies, such as biosensors and miniaturization, which are enabling the development of more accurate and user-friendly test strips. Additionally, the increasing focus on personalized medicine and the growing demand for home healthcare are expected to drive the demand for test strips in the coming years. Furthermore, the emergence of e-commerce platforms and the increasing availability of over-the-counter test strips are expected to boost the market growth.

Current Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Request sample copy

Test Strip Market Insights, By Product Type - Glucose Test Strip Dominate the Market due to the Increasing Prevalence of Diabetes

In terms of product type, the glucose test strips segment is expected to contribute the highest share of the market with 29.2% in 2025 owing to the increasing prevalence of diabetes worldwide. With the rising number of individuals diagnosed with diabetes, the demand for effective and convenient glucose monitoring solutions has skyrocketed. Glucose test strips have become an essential tool for diabetic patients to regularly check their blood sugar levels and manage their condition effectively.

One of the key factors driving the growth of glucose test strips is the growing awareness about the importance of self-monitoring blood glucose (SMBG) among diabetic patients. For instance, in May 2022, OmegaQuant, a leader in at-home health testing solutions, launched its HbA1c blood sugar testing kit. This innovative product allows users to conveniently measure their hemoglobin A1c levels—a key indicator of glucose metabolism—through a simple finger stick at home, eliminating the need for traditional blood draws and lab visits.

Test Strip Market Insights, By Application - Diabetes Management Applications Lead the Way owing to Emphasis on Blood Glucose Control

In terms of application, the diabetes management segment is expected to contribute the highest share of the market with 32.1% in 2025. The increasing focus on effective diabetes management has been a major driver for the demand for test strips, particularly glucose test strips. With the rising global burden of diabetes, healthcare systems and individuals alike are placing greater emphasis on maintaining optimal blood glucose control to prevent complications and improve patient outcomes.

Diabetes management involves regular monitoring of blood glucose levels, and test strips play a crucial role in this process. Patients with diabetes, both Type 1 and Type 2, rely on test strips to measure their blood glucose levels multiple times a day. This enables them to adjust their insulin doses, modify their diet, and make lifestyle changes to keep their glucose levels within the target range. The frequent need for testing has resulted in a high consumption of test strips, contributing to their dominant market share.

Test Strip Market Insights, By End User - Hospitals and Clinics Lead the Adoption of Test Strip as Quality Care and Patient Monitoring Drive Demand

In terms of end user, the hospitals & clinics segment is expected to contribute the highest share of the market with 32.2% in 2025. Hospitals and clinics are the primary healthcare settings where test strips are extensively used for various diagnostic and monitoring purposes. The increasing burden of chronic diseases, such as diabetes and cardiovascular disorders, has led to a higher influx of patients in these facilities, driving the demand for test strips.

In hospitals and clinics, test strips are routinely used for bedside testing, point-of-care testing, and regular patient monitoring. Healthcare professionals rely on test strips to quickly assess patients' vital parameters, such as blood glucose levels, ketone levels, and urine analysis, enabling rapid decision-making and treatment adjustments. The convenience and speed of test strip-based diagnostics have made them an integral part of patient care in these settings.

Regional Insights

To learn more about this report, Request sample copy

North America Test Strip Market Analysis and Trends

In North America, the dominance in the global test strip market with a share of 44.3% in 2025 can be attributed to several factors. The region boasts a well-established healthcare infrastructure, high adoption of advanced medical technologies, and a strong presence of key market players. The U.S., in particular, has been at the forefront of test strip innovation, with companies like Abbott Laboratories and Johnson & Johnson leading the way. The rising prevalence of urinary tract infections (UTIs) in the U.S. is driving the demand for test strips as a convenient and efficient diagnostic solution, thereby supporting the growth of the test strip market.

For example, a study conducted by Eastern Virginia Medical School in November 2023 revealed that nearly 40% of women in the U.S. are likely to experience UTIs at some stage in their lives, underscoring the need for swift and accurate diagnostic methods. Test strips offer an easy-to-use, cost-effective option for healthcare providers to quickly detect infections by identifying indicators such as white blood cells and nitrites in urine. This growing population segment is expected to fuel the demand for UTI test strips, further propelling market expansion across the region.

Asia Pacific Test Strip Market Analysis and Trends

Meanwhile, the Asia Pacific region is expected to exhibit the fastest growth in the global test strip market with a share of 29.1% in 2025. This growth can be ascribed to the rapidly expanding healthcare sector, increasing awareness about chronic disease management, and rising disposable incomes in countries like China and India. The region's large population base, coupled with the growing prevalence of diabetes and other lifestyle-related disorders, has created a significant demand for test strips. Moreover, government initiatives to improve healthcare access and the emergence of local manufacturers have further propelled market growth in the Asia Pacific. Countries like Japan and South Korea have also been quick to adopt advanced test strip technologies, contributing to the region's fast-paced growth.

Global Test Strip Market Outlook for Key Countries

U.S. Test Strip Market Trends

The U.S. market for test strips is characterized by a strong emphasis on innovation and advanced technologies. Major players like Abbott Laboratories and LifeScan (a subsidiary of Johnson & Johnson) have been instrumental in driving market growth through their cutting-edge products and extensive distribution networks. The country's well-established healthcare system, coupled with a high prevalence of diabetes and other chronic conditions, has sustained a robust demand for test strips.

In March 2024, Nova Biomedical, a leading provider of advanced biosensor technologies for medical diagnostics, announced the U.S. release of its new-generation StatStrip Glucose Hospital Meter System, following U.S. FDA 510(k) clearance. The upgraded meter retains compatibility with Nova’s U.S. FDA-approved test strip for critically ill patients, while introducing a host of new features, including a Linux-based operating system for improved cybersecurity, wireless charging, radio frequency identification, FID data entry, a durable external casing, sealed battery design, and compatibility with Clorox Bleach and Super-Sani Wipes for disinfection.

U.K. Test Strip Market Trends

The U.K. test strip market is driven by increasing prevalence of chronic conditions such as diabetes, a growing elderly population, and the rising emphasis on preventive healthcare. Test strips play a crucial role in point-of-care diagnostics, offering quick and accurate results for blood glucose monitoring, cholesterol levels, and other critical health markers. The National Health Service (NHS) initiatives promoting self-monitoring of chronic diseases have further accelerated the adoption of test strips among patients and healthcare providers.

For instance, in April 2024, OVUM, a pioneering brand in women's health diagnostics, launched the U.K.'s first fully recyclable early-detection pregnancy tests. The products are available in Sainsbury's stores across the U.K. As a certified B Corporation, a type of certification for companies that meet high standards of social and environmental performance, accountability, and transparency. OVUM demonstrates a strong commitment to environmental and social responsibility. This sustainability focus, combined with its innovative product offering, is expected to appeal to eco-conscious consumers.

Japan Test Strip Market Trends

The test strip market in Japan is experiencing steady growth, primarily driven by the increasing prevalence of diabetes and the aging population. Self-monitoring blood glucose (SMBG) devices, which include test strips, are gaining popularity due to their convenience and the growing emphasis on preventive healthcare. Technological advancements, such as the development of smart test strips and continuous glucose monitoring (CGM) systems, are also contributing to market growth.

For example, in June 2022, Kaneka Corporation, a Japan-based chemical and life sciences company, launched the Kaneka Immunochromatography SARS-CoV-2 Ag, a COVID-19 antigen test kit authorized for sale and use in Japan as of June 2022. Priced at USD 91.29 Bn (for 10 tests), this in-vitro diagnostic kit offers quick, 10-minute detection of COVID-19 antigens from nasopharyngeal and nasal cavity specimens, using a simple immunochromatography method without requiring specialized equipment. The launch helps address test kit shortages in Japan by ensuring a stable domestic supply.

Canada Test Strip Market Trends

The Canada test strip market is growing steadily, driven by the rising prevalence of diabetes, increasing awareness of self-monitoring practices, and advancements in test strip technologies. Government initiatives and healthcare support further promote the use of blood glucose monitoring solutions, while leading companies like Abbott, Roche, and Ascensia continue to innovate. However, challenges such as high costs and competition from alternative technologies, including continuous glucose monitoring, may impact market dynamics.

For example, in January 2023, Empower Clinics Inc., a healthcare company, announced that its subsidiary, MediSure Canada, secured approval for its MediSure Empower test strips to be included in the formularies of key government jurisdictions, including Alberta, Quebec, Veterans Affairs Canada, and Non-insured Health Benefits for First Nations and Inuit.

India Test Strip Market Trends

India's market for test strips is rapidly evolving, driven by the country's large diabetic population and increasing healthcare awareness. The government's initiatives to improve healthcare access and affordability have been crucial in driving market growth. Local companies like Dr. Morepen and Piramal Enterprises have played a significant role in providing cost-effective test strip solutions to the masses.

For example, in May 2023, Roche Diabetes Care India (RDC India), a subsidiary of Roche Group, expanded its local manufacturing capabilities for the Accu-Chek Active blood glucose monitor. RDC India now produces the Accu-Chek Active device within India, marking a strategic shift from previous manufacturing locations to enhance local supply chain resilience and support the Indian market.

End User Feedback and Unmet Needs in the Global Test Strip Market

• End users of test strips across key sectors—particularly healthcare providers, industrial quality assurance teams, and government regulatory bodies—have shared a mix of positive feedback and recurring concerns regarding product performance and operational usability. A notable example of user satisfaction comes from diabetes management clinics in Europe, where healthcare professionals report high confidence in the accuracy and consistency of glucose test strips. The integration of Bluetooth-enabled meters with smartphone apps has enhanced patient engagement by facilitating real-time data tracking and remote monitoring, ultimately supporting better glycemic control and adherence to therapy plans. Conversely, a frequently cited concern stems from industrial users in environmental testing and water quality monitoring, who highlight the limited sensitivity of some test strips in detecting trace contaminants such as heavy metals and nitrates. This challenge often necessitates repeat testing or reliance on more advanced lab equipment, which increases operational costs and reduces testing efficiency in field settings.
• Unmet needs in the test strip market primarily revolve around the demand for enhanced sensitivity and broader detection ranges, especially in industrial and environmental applications, where accurate, low-concentration detection is critical. Additionally, there is a need for more customizable solutions, such as sector-specific calibration standards, improved environmental durability (e.g., resistance to humidity or extreme temperatures), and cost-effective bulk packaging options for high-volume users. Addressing these needs presents significant opportunities for manufacturers to differentiate their products, improve customer retention, and expand market reach. By investing in R&D for advanced strip chemistries, developing multi-parameter test solutions, and providing better technical support, industry players can not only improve product-market fit but also contribute to higher end-user satisfaction, regulatory compliance, and long-term market growth.

Market Players, Key Development, and Competitive Intelligence

To learn more about this report, Request sample copy

Key Developments

• In February 2025, Safer Sips, a safety-focused innovator, launched its Check Your Drink (CYD) Test Strip in New Zealand, following the 2024 Mama Hooch drink spiking incident in Christchurch. CYD is the first evidential drink spiking test strip available in the country, empowering individuals to detect GHB, Ketamine, and over 650 other amine drugs, including MDMA and Amphetamines, in seconds.
• In October 2024, First Response, a trusted brand under Church & Dwight in women’s health and reproductive care, launched the Multi Check Pregnancy Test Kit featuring EasyCup—a first-of-its-kind, all-in-one pregnancy test cup. EasyCup combines a urine collection cup with an integrated test strip, providing users with a cleaner, more controlled testing experience. The kit also includes two Rapid Result pregnancy tests for added reassurance. This innovation, inspired by consumer habits and clinical familiarity, simplifies pregnancy testing, offering convenience and accuracy.
• In August 2024, J Mitra & Company, a leading Indian in-vitro diagnostics manufacturer, launched the Dengue NS1 Antigen Self-Test Kit in August 2024, marking India’s first home-use test for early dengue detection. The kit enables users to perform self-testing from Day One of fever, offering results in 20 minutes. It detects all four dengue virus serotypes with high sensitivity and specificity. This easy-to-use, two-step Point of Care Test (POCT) empowers early intervention, especially for severe cases like Dengue Haemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS).
• In June 2024, Prevounce Health, a leading U.S.-based provider of remote care management solutions, launched the Pylo GL1-LTE Blood Glucose Meter—its first cellular-connected glucometer designed for remote patient monitoring (RPM) in diabetes care. The U.S. FDA-cleared and FCC-certified device ensures reliable data transmission via 4G connectivity, requiring no setup by patients. It integrates seamlessly with Prevounce’s RPM platform and the Pylo cloud API, enhancing glycemic control through real-time monitoring.

Top Strategies Followed by Global Test Strip Market Players

• Established players in the global test strip market are focusing on extensive research and development to innovate high-performance products. These companies are investing heavily in R&D to develop advanced test strips with improved accuracy, sensitivity, and user-friendliness. For instance, Abbott Laboratories has been continuously enhancing its FreeStyle Libre continuous glucose monitoring system, which uses test strips to measure glucose levels in interstitial fluid.
  • For Instance, in March 2025, Abingdon Health, a rapid diagnostics developer, is launching its saliva-based pregnancy test, Salistick in Germany and other European markets. After success in the U.K., it received an initial order of 70,000 tests, with more expected. Salistick detects pregnancy hormone β-hCG in saliva, providing a convenient and accurate alternative to urine tests.

• Mid-level players in the test strip market are focusing on delivering cost-effective solutions to target price-sensitive consumers. These companies are developing quality test strips that offer reliable results at affordable prices. By optimizing manufacturing processes and sourcing materials efficiently, mid-level players aim to provide competitive products without compromising on performance.
  • For instance, in September 2024, Mankind Pharma Ltd. introduced RAPID NEWS self-test kits targeting dengue, urinary tract infections (UTIs), and early menopause—three pressing health concerns in India. With nearly 300,000 dengue cases reported in 2023 and UTIs affecting around 30% of Indian women, early and private testing is critical.

• Small-scale players in the global test strip market are adopting niche specialization strategies to differentiate themselves from larger competitors. These companies are developing test strips with unique features or targeting specific market segments, such as pediatric or veterinary testing. By focusing on niche markets, small-scale players can offer innovative products that cater to specific customer needs.
  • For instance, in June 2022, Mylab Discovery Solutions launched PregaScreen, an at-home pregnancy test kit marking its entry into female healthcare. The kit offers quick, 99.99% accurate results and is available across Indian pharmacies. The global market for such tests is growing steadily, driven by rising unplanned pregnancies, better diagnostics, and lifestyle changes.

Market Report Scope

Test Strip Market Report Coverage

Test Strip Market Dynamics

To learn more about this report, Request sample copy

Test Strip Market Driver - Increasing prevalence of diabetes

The rising prevalence of diabetes worldwide is a significant driver propelling the growth of the global test strip market. As the number of individuals diagnosed with diabetes continues to surge, the demand for effective and convenient blood glucose monitoring solutions, such as test strips, is experiencing a substantial increase. Diabetes, a chronic metabolic disorder characterized by elevated blood sugar levels, requires regular monitoring to prevent complications and maintain optimal health outcomes. Test strips have become an indispensable tool for diabetic patients, enabling them to easily and accurately measure their blood glucose levels at home or on the go. With the growing awareness about the importance of self-monitoring and disease management, coupled with the expanding diabetic population, the test strip market is poised for significant growth in the coming years.

Manufacturers are focusing on developing advanced test strips that offer improved accuracy, faster results, and enhanced user-friendliness to cater to the evolving needs of diabetic patients worldwide. For instance, in November 2024, WHO reports that lobal diabetes cases have quadrupled since 1990, now affecting over 800 million adults. Low- and middle-income countries face the biggest rise and treatment gaps, with nearly 450 million untreated patients. South-East Asia and Eastern Mediterranean regions have high diabetes rates but low treatment coverage.

Test Strip Market Opportunity - Technological advancements in testing devices

The global test strip market is poised for significant growth and innovation, driven by the rapid technological advancements in testing devices. The development of smart, connected, and user-friendly testing devices presents a remarkable opportunity for the market to expand and cater to the evolving needs of patients and healthcare professionals. These advanced devices integrate cutting-edge technologies, such as wireless connectivity, data management systems, and intuitive user interfaces, enabling seamless and efficient testing experiences. By leveraging these technological advancements, manufacturers can create test strips that are more accurate, reliable, and compatible with a wide range of testing devices. Moreover, the integration of test strips with smartphone applications and cloud-based platforms allows for real-time data tracking, remote monitoring, and personalized insights, empowering patients to take greater control of their health.

For instance, in September 2024, Trividia Health, Inc., a leader in diabetes care solutions, launched the TRUENESS Blood Glucose Monitoring System. This affordable, accurate, and easy-to-use system helps users manage blood glucose effectively. The TRUENESS AIR meter offers Bluetooth connectivity to the TRUE MANAGER AIR app for tracking daily activities alongside glucose levels. Available from September 2024, TRUENESS will be sold through pharmacies, distributors, and online platforms like Amazon.

Analyst Opinion (Expert Opinion)

• The global test strip market is witnessing robust growth driven by rapid technological advancements in biosensor technologies, increasing prevalence of chronic diseases such as diabetes, and supportive regulatory frameworks promoting early diagnostics and home healthcare solutions. Innovations like continuous glucose monitoring integration and improved strip accuracy have expanded usability and patient compliance. Additionally, rising awareness and demand for quick, reliable, and affordable diagnostic tools in emerging economies present significant opportunities. However, challenges such as high production costs, reimbursement uncertainties, and stringent regulatory approvals continue to impact market penetration, requiring manufacturers to innovate cost-effective solutions and streamline approval processes.
• Several key events have facilitated knowledge exchange and policy dialogue within the broader diagnostic and online health service sectors. Notable conferences such as the Diabetes Technology Meeting (DTM) held annually since 2021, the World Congress on Diabetes and Metabolism (2022), and the Digital Health Summit (2023) have showcased cutting-edge diagnostic technologies, including test strip advancements and telemedicine integration. Real-world initiatives like Abbott’s FreeStyle Libre expansion and government-led pilot programs for remote patient monitoring underscore the market’s evolving landscape. These programs enhance early disease management and foster public-private collaborations, setting the stage for accelerated adoption and innovation in the test strip market globally.

Market Segmentation

•  Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Glucose Test Strips
  • Ketone Test Strips
  • Cholesterol Test Strips
  • Hemoglobin A1c Test Strips
  • Pregnancy Test Strips
  • Urine Test Strips
  • Ovulation Test Strips
  • Others
•  Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Diabetes Management
  • Cardiovascular Diseases
  • Pregnancy and Fertility
  • Infectious Diseases
  • Drug Testing
  • General Health Monitoring
•  End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals & Clinics
  • Home Care Settings
  • Diagnostic Laboratories
  • Research Institutes
  • Others
•  Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Abbott Laboratories
  • Roche Diagnostics
  • Bayer AG
  • Ascensia Diabetes Care
  • LifeScan
  • Arkray
  • Nova Biomedical
  • Menarini Diagnostics
  • DarioHealth Corp
  • Prometheus Laboratories
  • EKF Diagnostics
  • Senzoor
  • Infopia
  • Biolytical Laboratories
  • Atlas Copco

Sources

Primary Research Interviews

• Industry Experts (e.g., healthcare professionals, medical device specialists, or laboratory technicians)
• Manufacturers and Distributors of Test Strip
• Regulatory Bodies and Health Authorities (e.g., U.S. FDA, EMA)
• End Users (e.g., hospitals, clinics, laboratories)
• Healthcare Consultants (focused on diagnostics and medical devices)

Databases

• World Health Organization (WHO) (Global health reports and disease prevalence affecting diagnostics)
• Centers for Disease Control and Prevention (CDC) (Health data and reports on diagnostic trends)
• S. Food and Drug Administration (FDA) (Regulatory data and device approvals)
• European Medicines Agency (EMA) (Regulatory approvals and guidelines for diagnostic devices)
• OECD Health Data (Health statistics and diagnostic device usage across countries)
• National Institutes of Health (NIH) (Research and clinical trial data related to diagnostics)
• Global Health Observatory (GHO) (Health data from WHO)
• UNICEF (Global health reports and data on child and maternal health diagnostics)

Magazines

• Diagnostic and Interventional Cardiology (Covers developments in diagnostics, including test strips for various conditions)
• MedTech Dive (Updates on medical device innovations and trends, including test strips)
• Clinical Chemistry (Research on clinical diagnostics, including test strips)
• Lab Medicine (Publications related to laboratory diagnostic tools, including test strips)
• The Journal of Diabetes Science and Technology (Focus on diabetes testing strips and devices)

Journals

• Diagnostic and Interventional Cardiology (Covers developments in diagnostics, including test strips for various conditions)
• MedTech Dive (Updates on medical device innovations and trends, including test strips)
• Clinical Chemistry (Research on clinical diagnostics, including test strips)
• Lab Medicine (Publications related to laboratory diagnostic tools, including test strips)
• The Journal of Diabetes Science and Technology (Focus on diabetes testing strips and devices)

Newspapers

• Diagnostic and Interventional Cardiology (Covers developments in diagnostics, including test strips for various conditions)
• MedTech Dive (Updates on medical device innovations and trends, including test strips)
• Clinical Chemistry (Research on clinical diagnostics, including test strips)
• Lab Medicine (Publications related to laboratory diagnostic tools, including test strips)
• The Journal of Diabetes Science and Technology (Focus on diabetes testing strips and devices)

Associations

• International Medical Device Regulators Forum (IMDRF) (Global collaboration for medical device regulation)
• American Association for Clinical Chemistry (AACC) (Support for diagnostic professionals and insights into test strip technologies)
• World Health Organization (WHO) - Prequalification Programme (Standards for diagnostic devices including test strips)
• Medical Device Manufacturers Association (MDMA) (Advocacy for medical device manufacturers, including diagnostic tools)
• Association for the Advancement of Medical Instrumentation (AAMI) (Standards and insights into medical devices including test strips)

Public Domain Sources

• CDC WONDER (Health-related data and statistics from the CDC)
• gov (Database of clinical trials, including those involving test strips)
• gov (Publicly available datasets, including healthcare and medical diagnostics)
• Eurostat (Statistical data on health and medical devices across European countries)
• World Bank Open Data (Economic and healthcare datasets, relevant for market analysis)

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years